Protagenic Therapeutics Inc. (PTIX)

[angel38]

Stakeholders interest not Shareholders.

Mar-2012

Other Events



Item 8.01 Other Events.
On March 29, 2012, Atrinsic, Inc. announced that it will not be filing its Annual Report on Form 10-K for the fiscal year ending December 31, 2011 and will also cease filing future reports under the Securities Exchange Act of 1934, as amended. As a result of this decision, public information about the company will be limited significantly going forward. The company's board of directors determined that it is in the best interest of the company's stakeholders to preserve the company's limited cash resources and therefore not to incur the costs required to prepare and file its Annual Report on Form 10-K and other reports otherwise required under the Securities Exchange Act of 1934. In connection with its decision, the company intends to file a Form 15 "Certification and Notice of Termination of Registration Under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934."